• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DVL 0.00% 1.4¢

DORSAVI LTD - Charts / Financials

dorsaVi Ltd is an Australia-based company focused on developing motion analysis device... dorsaVi Ltd is an Australia-based company focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.58pm 21/11/2024 (20 minute delay) ?
Day
Open 1.4¢   Day High 1.4¢   Day Low 1.3¢
Daily Volume 4889735
Bids   Sellers
Number Price Volume   Number Price Volume
1 1.3¢ 162952   3 1.4¢ 353730

Directors & Senior Management

Dr. Andrew James Ronchi Chief Executive Officer, Executive Director
Mr. Aaron Chan Chief Financial Officer
Mr. John Kowalczyk President of Dorsavi US
Mr. Daniel Ronchi Chief Technical Officer
Mr. Dave Wildermuth Chief Marketing Officer
Ms. Meagan Blackburn Chief Innovation Officer
Mark Stephen Heaysman Group OH&S Compliance Business Manager
Mr. Matthew May Director National and Customer Relationships
Ms. Sarah Riseley Senior Market Development lead
Dr. Muhammad Umer Chief Product Officer
Dr. Michael Panaccio Non-Executive Interim Chairman of the Board
Mr. Gernot Abl Non-Executive Director
Mr. Vineet Agarwal Non-Executive Director
Dr. Michael Gordon Winlo Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
1.4¢
Change
0.000(0.00%)
Mkt cap ! $7.367M
Open High Low Value Volume
1.4¢ 1.4¢ 1.3¢ $65.31K 4.889M

Buyers (Bids)

No. Vol. Price($)
1 162952 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 353730 3
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
1.4¢
  Change
0.000 ( 2.10 %)
Open High Low Volume
1.4¢ 1.4¢ 1.2¢ 3218184
Last updated 15.58pm 21/11/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.